Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Frank E. Bellot"'
Autor:
Frank E. Bellot, Frits S.A.M. van Dam, Wim H. van Harten, Rudi M. H. Roumen, Valesca P. Retèl, J. Marjan Hummel, Cees van Krimpen, Jolien M. Bueno-de-Mesquita, Kirsten F. L. Douma, Marc J. van de Vijver, Sabine C. Linn, Kim Karsenberg
Publikováno v:
International journal of technology assessment in health care, 25(1), 73-83. Cambridge University Press
Objectives:Constructive Technology Assessment (CTA) is a means to guide early implementation of new developments in society, and can be used as an evaluation tool for Coverage with Evidence Development (CED). We used CTA for the introduction of a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d414cad9dc945aab4ad5857c5165cd
https://doi.org/10.1017/s0266462309090102
https://doi.org/10.1017/s0266462309090102
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(42)
A 19-year-old woman with a Syrian background complained of genital ulcers. Sexually transmitted disease was excluded. She was also suffering from oral aphthae and had been treated by a dermatologist for acne. The diagnosis of Behçet disease was made
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a28d73a54228d45c91dbb4e5aca43ea
https://pubmed.ncbi.nlm.nih.gov/22027458
https://pubmed.ncbi.nlm.nih.gov/22027458
Autor:
Annuska M. Glas, Frank E. Bellot, Douwe Atsma, Cees van Krimpen, Kirsten F. L. Douma, Frits S.A.M. van Dam, Tin S. Wu, Johannes L. Peterse, Harm van Tinteren, Valesca P. Retèl, Sjoerd Rodenhuis, Jelle Wesseling, Jolien M. Bueno-de-Mesquita, Emiel J. Th. Rutgers, Wim H. van Harten, Guido Brink, Rudi M. H. Roumen, Sabine C. Linn, Marc J. van de Vijver, Arno Floore, Kim Karsenberg, Laura J. van't Veer
Publikováno v:
The Lancet, 8(12), 1079-1089. Elsevier
lancet oncology, 8(12), 1079-1087. Lancet Publishing Group
lancet oncology, 8(12), 1079-1087. Lancet Publishing Group
Summary Background A microarray-based 70-gene prognosis signature might improve the selection of patients with node-negative breast cancer for adjuvant systemic treatment. The main aims of this MicroarRAy PrognoSTics in Breast CancER (RASTER) study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0cddc840b2fd2a52c7684dfbeb83ee0
https://pubmed.ncbi.nlm.nih.gov/18308244
https://pubmed.ncbi.nlm.nih.gov/18308244
Autor:
Valesca P. Ret?l, Jolien M. Bueno-de-Mesquita, Marjan J. M. Hummel, Marc J. van de Vijver, Kirsten F. L. Douma, Kim Karsenberg, Frits S. A. M. van Dam, Cees van Krimpen, Frank E. Bellot, Rudi M. H. Roumen, Sabine C. Linn, Wim H. van Harten
Publikováno v:
International Journal of Technology Assessment in Health Care; Jan2009, Vol. 25 Issue 1, p73-83, 11p